NAA15 antibody (N-Term)
Quick Overview for NAA15 antibody (N-Term) (ABIN633172)
Target
See all NAA15 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- NARG1 antibody was raised against the N terminal of NARG1
-
Purification
- Affinity purified
-
Immunogen
- NARG1 antibody was raised using the N terminal of NARG1 corresponding to a region with amino acids LRPAQRASWIGYAIAYHLLEDYEMAAKILEEFRKTQQTSPDKVDYEYSEL
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
NARG1 Blocking Peptide, (ABIN5614916), is also available for use as a blocking control in assays to test for specificity of this NARG1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NARG1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NAA15 (N(alpha)-Acetyltransferase 15, NatA Auxiliary Subunit (NAA15))
-
Alternative Name
- NARG1
-
Background
- The ARD1A-NARG1 complex displays alpha (N-terminal) acetyltransferase activity that may be important for vascular, hematopoietic and neuronal growth and development. NARG1 is required to control retinal neovascularization in adult ocular endothelial cells. In complex with G22P1 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter.
-
Molecular Weight
- 101 kDa (MW of target protein)
Target
-